Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial

Author:

Feld Jordan J,Kandel Christopher,Biondi Mia J,Kozak Robert A,Zahoor Muhammad Atif,Lemieux Camille,Borgia Sergio M,Boggild Andrea K,Powis Jeff,McCready Janine,Tan Darrell H S,Chan Tiffany,Coburn Bryan,Kumar Deepali,Humar Atul,Chan Adrienne,O'Neil Braden,Noureldin Seham,Booth Joshua,Hong Rachel,Smookler David,Aleyadeh Wesam,Patel Anjali,Barber Bethany,Casey Julia,Hiebert Ryan,Mistry Henna,Choong Ingrid,Hislop Colin,Santer Deanna M,Lorne Tyrrell D,Glenn Jeffrey S,Gehring Adam J,Janssen Harry L A,Hansen Bettina E

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference39 articles.

1. Remdesivir for the treatment of COVID-19—final report;Beigel;N Engl J Med,2020

2. Dexamethasone in hospitalized patients with COVID-19—preliminary report;Horby;N Engl J Med,2020

3. SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with COVID-19;Chen;N Engl J Med,2020

4. Early administration of oral oseltamivir increases the benefits of influenza treatment;Aoki;J Antimicrob Chemother,2003

5. Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households;Carrat;Antivir Ther,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3